TY - JOUR T1 - Artificial intelligence in GI endoscopy: stumbling blocks, gold standards and the role of endoscopy societies JF - Gut JO - Gut DO - 10.1136/gutjnl-2020-323115 SP - gutjnl-2020-323115 AU - Rüdiger Schmitz AU - Rene Werner AU - Alessandro Repici AU - Raf Bisschops AU - Alexander Meining AU - Michael Zornow AU - Helmut Messmann AU - Cesare Hassan AU - Prateek Sharma AU - Thomas Rösch Y1 - 2021/01/21 UR - http://gut.bmj.com/content/early/2021/03/02/gutjnl-2020-323115.abstract N2 - Artificial intelligence has been portrayed as a silver bullet for a number of challenges encountered in gastrointestinal (GI) endoscopy and beyond. Intense research, commercial and media focus have led to the publication of studies with modest patient numbers and comparatively simple technology. There is no doubt that machine learning (ML) will be a determining medical development for the years to come. However, now that the dust has begun to settle, we are at a critical juncture where the focus is shifting from preclinical work toward the role of ML in clinical practice. Current issues relate to the evaluation and testing of AI and ML systems, especially regarding patient outcomes, and to regulatory issues surrounding implementation. Many of these aspects pertain to one overarching question: how can we ensure that preclinical results translate into trustworthy clinical reality?For the endoscopist, whether as a reader, a reviewer or a potential user of AI, it becomes increasingly important to understand the technical aspects of the systems and their performance measurements in order to realistically assess their practical value. Therefore, with GI endoscopy ML at the jump-off point from proof-of-principle studies1–7 to clinical trials8–12, van der Sommen et al provided us with an accessible guide to understand, assess and critically review the current ML endoscopy literature.13Our commentary highlights selected aspects of this review and AI as a whole and elaborates on the role of the GI endoscopy community and how it may both experience and frame the way ahead. In particular, we advocate a close collaboration of technology scientists and clinicians from early development phases onward to allow for the development of well-tailored AI algorithms and realistic preclinical testing. More transparency is needed with respect to the training data and the algorithm development process. In addition, in the legislative … ER -